Skip to main content


Fig. 5 | Cardiovascular Diabetology

Fig. 5

From: Aspirin has potential benefits for primary prevention of cardiovascular outcomes in diabetes: updated literature-based and individual participant data meta-analyses of randomized controlled trials

Fig. 5

Effect of aspirin on the primary prevention of major adverse cardiovascular events, all-cause mortality, myocardial infarction, stroke, and cardiovascular disease death in people with diabetes, based on pooled analysis of individual level data from three trials. CI, confidence interval (bars); CVD, cardiovascular disease; MACE, major adverse cardiovascular events; OR, odds ratio. BP, blood pressure; CI, confidence interval (bars); OR, odds ratio; RA, rheumatoid arthritis

Back to article page